09/14/2026
The conversation around testosterone and women’s health is getting louder.
And on September 17, it’s reaching the FDA.
The FDA Office of Women’s Health and Center for Drug Evaluation and Research are hosting a public workshop focused on testosterone use in menopausal women.
The meeting will examine the current evidence, important knowledge gaps, and where research and treatment need to go next — including questions around sexual function, cognition, mood, musculoskeletal health, testosterone testing, and long-term safety.
This matters.
Testosterone is already being used off-label in menopausal women, but we still lack an FDA-approved testosterone product specifically for women in the United States. The FDA workshop is intended to help inform future research and potential drug development in this area.
For women navigating perimenopause and menopause, this is an important conversation to watch.
At Triple Health Clinic, we believe women deserve thoughtful, evidence-based discussions about all of their options — including what we know, what we don’t know yet, and what may be appropriate for the individual woman.
I’ll be following this meeting closely and sharing what comes out of it.
Learn • Connect • Thrive 💜
Triple Health Clinic
Now accepting new patients.
Call or text the clinic to learn more at 319-601-5686.